axatilimab-csfr
axatilimab-csfr is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand name including NIKTIMVO. Available dosage form: injection.
Drug Details
- Generic Name
- axatilimab-csfr
- Brand Names
- NIKTIMVO
- Application Number
- BLA761411
- Sponsor
- Incyte Corporation
- NDC Codes
- 8
- Dosage Forms
- INJECTION
- Routes
- INTRAVENOUS
- Active Ingredients
- AXATILIMAB
Indications and Usage
1 INDICATIONS AND USAGE NIKTIMVO is indicated for the treatment of chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg. NIKTIMVO is a colony stimulating factor-1 receptor (CSF-1R)-blocking antibody indicated for the treatment of chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg. ( 1 )